Single dose of propofol causing propofol infusion syndrome in a newborn
Author(s) -
Carolina Michel-Macías,
Deneb Algedi Morales-Barquet,
A M Reyes-Palomino,
J A Machuca-Vaca,
Alejandra Orozco-Guillén
Publication year - 2018
Publication title -
oxford medical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.169
H-Index - 9
ISSN - 2053-8855
DOI - 10.1093/omcr/omy023
Subject(s) - medicine , propofol , rhabdomyolysis , metabolic acidosis , anesthesia , bolus (digestion) , acidosis , surgery
Propofol infusion syndrome (PRIS) is a rare syndrome originally described in critically ill children undergoing long-term (> 48 h) propofol infusion at high doses (> 4 mg/kg/h). Severe metabolic acidosis, rhabdomyolysis, renal failure and fatal cardiac failure are the features. Herein, we present a case of a newborn who developed PRIS after a single bolus dose of propofol at 3.2 mg/kg/do, developing rhabdomyolysis and severe metabolic acidosis, with a successful outcome after medical therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom